SYS-CON MEDIA Authors: Pat Romanski, Gary Arora, Zakia Bouachraoui, Yeshim Deniz, Liz McMillan

News Feed Item

WATER Study One-Year Data and WATER II Primary Endpoint Data for PROCEPT BioRobotics’ Aquablation® Therapy to be Presented at AUA 2018

PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced today that the company’s Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH) will be presented at several different educational sessions at the American Urological Association (AUA) Annual Meeting in San Francisco, May 18 – 21, 2018.

One-year follow-up data of the global Phase III WATER Study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue) comparing Aquablation therapy against transurethral resection of the prostate (TURP) will be presented by Peter Gilling, MD, co-principal investigator of the WATER Study and professor of surgery at the University of Auckland, Bay of Plenty Clinical School Tauranga, New Zealand. The session, titled “PD64-01 - The WATER Study Clinical Results – A Phase III blinded randomized trial of Aquablation vs. TURP with Blinded Outcome Assessment for Moderate-to-Severe LUTS in men with BPH,” will take place on Monday, May 21 at 1 pm PST in Moscone Convention Center West, room 2022. This one-year data will build on the WATER Study primary endpoint data featured at AUA 2017, which showed a superior safety profile for Aquablation therapy with very strong efficacy outcomes comparable to TURP.

The WATER II Study, evaluating the safety and efficacy of Aquablation therapy in large prostates 80 to 150 milliliters (mL) in size, has been accepted as a late-breaking abstract at the conference. The company’s second Phase III pivotal study, WATER II enrolled 101 patients at 16 sites in the U.S. and Canada with the intent to validate and extend upon the results from the initial WATER Study, which, in a subgroup of patients with prostates volumes of 50 to 80 mL, showed both a superior safety profile as well as superiority in International Prostate Symptom Score (IPSS) improvement. The presentation, titled “LBA-12 - Aquablation Procedural Outcomes for BPH in Large Prostates (80-150g): Results from the WATER II Study,” will be given by Mihir Desai, MD, Professor of Clinical Urology and Vice Chair, New Technology & Innovation at the Keck School of Medicine of USC, during the plenary session, “Next Frontier,” on Sunday, May 20 at 4 pm PST in Moscone Convention Center North, room Hall E.

In addition, Aquablation therapy will be presented at two pre-recorded live case video sessions as well as at multiple moderated poster sessions, including outcomes assessments of Aquablation therapy from the WATER Study in patients with larger prostates as well as the overall impact of heat-free waterjet resection on sexual function.

“The primary endpoint results of the WATER Study demonstrated that Aquablation therapy offers significant clinical advantages over TURP and we are excited to share the one-year results, supporting the durability of Aquablation therapy,” said Nikolai Aljuri, Ph.D., PROCEPT BioRobotics chief executive officer and founder. “We look forward to sharing the results from the WATER II study confirming that Aquablation can provide predictable and reproducible outcomes regardless of prostate volume or surgeon experience.”

Aquablation therapy, delivered by the AQUABEAM® System, is the first FDA granted surgical robot providing autonomous tissue removal for the treatment of BPH. Aquablation therapy combines the clarity of real-time, multi-dimensional imaging, autonomous robotics and heat-free waterjet ablation for targeted, controlled, and immediate removal of prostate tissue for the treatment of lower urinary tract symptoms (LUTS) caused by BPH.

For more information about Aquablation therapy with the AQUABEAM System, visit PROCEPT BioRobotics at AUA booth #5656 in Hall D of the Moscone Convention Center.

About PROCEPT BioRobotics

Based in Silicon Valley, PROCEPT BioRobotics is a privately-held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on BPH, PROCEPT BioRobotics offers the world’s first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size or surgeon experience. The AQUABEAM System is commercially available in the United States, Canada, Australia, New Zealand and select European markets. http://www.PROCEPT-BioRobotics.com

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
While a hybrid cloud can ease that transition, designing and deploy that hybrid cloud still offers challenges for organizations concerned about lack of available cloud skillsets within their organization. Managed service providers offer a unique opportunity to fill those gaps and get organizations of all sizes on a hybrid cloud that meets their comfort level, while delivering enhanced benefits for cost, efficiency, agility, mobility, and elasticity.
Isomorphic Software is the global leader in high-end, web-based business applications. We develop, market, and support the SmartClient & Smart GWT HTML5/Ajax platform, combining the productivity and performance of traditional desktop software with the simplicity and reach of the open web. With staff in 10 timezones, Isomorphic provides a global network of services related to our technology, with offerings ranging from turnkey application development to SLA-backed enterprise support. Leadin...
DevOps has long focused on reinventing the SDLC (e.g. with CI/CD, ARA, pipeline automation etc.), while reinvention of IT Ops has lagged. However, new approaches like Site Reliability Engineering, Observability, Containerization, Operations Analytics, and ML/AI are driving a resurgence of IT Ops. In this session our expert panel will focus on how these new ideas are [putting the Ops back in DevOps orbringing modern IT Ops to DevOps].
Darktrace is the world's leading AI company for cyber security. Created by mathematicians from the University of Cambridge, Darktrace's Enterprise Immune System is the first non-consumer application of machine learning to work at scale, across all network types, from physical, virtualized, and cloud, through to IoT and industrial control systems. Installed as a self-configuring cyber defense platform, Darktrace continuously learns what is ‘normal' for all devices and users, updating its understa...
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Concerns about security, downtime and latency, budgets, and general unfamiliarity with cloud technologies continue to create hesitation for many organizations that truly need to be developing a cloud strategy. Hybrid cloud solutions are helping to elevate those concerns by enabling the combination or orchestration of two or more platforms, including on-premise infrastructure, private clouds and/or third-party, public cloud services. This gives organizations more comfort to begin their digital tr...
Most organizations are awash today in data and IT systems, yet they're still struggling mightily to use these invaluable assets to meet the rising demand for new digital solutions and customer experiences that drive innovation and growth. What's lacking are potent and effective ways to rapidly combine together on-premises IT and the numerous commercial clouds that the average organization has in place today into effective new business solutions.
Keeping an application running at scale can be a daunting task. When do you need to add more capacity? Larger databases? Additional servers? These questions get harder as the complexity of your application grows. Microservice based architectures and cloud-based dynamic infrastructures are technologies that help you keep your application running with high availability, even during times of extreme scaling. But real cloud success, at scale, requires much more than a basic lift-and-shift migrati...
David Friend is the co-founder and CEO of Wasabi, the hot cloud storage company that delivers fast, low-cost, and reliable cloud storage. Prior to Wasabi, David co-founded Carbonite, one of the world's leading cloud backup companies. A successful tech entrepreneur for more than 30 years, David got his start at ARP Instruments, a manufacturer of synthesizers for rock bands, where he worked with leading musicians of the day like Stevie Wonder, Pete Townsend of The Who, and Led Zeppelin. David has ...
Darktrace is the world's leading AI company for cyber security. Created by mathematicians from the University of Cambridge, Darktrace's Enterprise Immune System is the first non-consumer application of machine learning to work at scale, across all network types, from physical, virtualized, and cloud, through to IoT and industrial control systems. Installed as a self-configuring cyber defense platform, Darktrace continuously learns what is ‘normal' for all devices and users, updating its understa...
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Addteq is a leader in providing business solutions to Enterprise clients. Addteq has been in the business for more than 10 years. Through the use of DevOps automation, Addteq strives on creating innovative solutions to solve business processes. Clients depend on Addteq to modernize the software delivery process by providing Atlassian solutions, create custom add-ons, conduct training, offer hosting, perform DevOps services, and provide overall support services.
Contino is a global technical consultancy that helps highly-regulated enterprises transform faster, modernizing their way of working through DevOps and cloud computing. They focus on building capability and assisting our clients to in-source strategic technology capability so they get to market quickly and build their own innovation engine.
When applications are hosted on servers, they produce immense quantities of logging data. Quality engineers should verify that apps are producing log data that is existent, correct, consumable, and complete. Otherwise, apps in production are not easily monitored, have issues that are difficult to detect, and cannot be corrected quickly. Tom Chavez presents the four steps that quality engineers should include in every test plan for apps that produce log output or other machine data. Learn the ste...
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...